To include your compound in the COVID-19 Resource Center, submit it here.

July 17 Financial Quick Takes: Chipscreen's Shanghai listing advances; plus Avrobio, Repligen and Seer

Chipscreen clears hurdle for Shanghai IPO

With registration of its application by China Securities Regulatory Commission, Shenzhen Chipscreen Biosciences Ltd. (Shenzhen, China) overcame the final hurdle for its proposed listing on Shanghai’s science and technology innovation board, also known as the STAR market.

Read the full 420 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers